Synonyms:Dofetilide, 115256-11-6, Tikosyn, Dofetilida, Dofetilidum, Dofetilidum [INN-Latin], Dofetilida [INN-Spanish], UK 68798, UK-68798, UK-68,798, C19H27N3O5S2, N-(4-(2-(methyl(2-(4-(methylsulfonamido)phenoxy)ethyl)amino)ethyl)phenyl)methanesulfonamide, Dofetilide (Tikosyn), beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide, CHEMBL473, R4Z9X1N2ND, N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide, CHEBI:4681, DTXSID5046433, 1-(4-Methanesulphonamidophenoxy)-2-[N-(4-methanesulphonamidophenethyl)-N-methylamino]ethane, N-[4-[2-[Methyl[2-[4-[(methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]methanesulfonamide, Methanesulfonamide, N-[4-[2-[methyl[2-[4-[(methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]-, NCGC00164549-01, UK 68789, Methanesulfonamide, N-(4-(2-(methyl(2-(4-((methylsulfonyl)amino)phenoxy)ethyl)amino)ethyl)phenyl)-, DTXCID3026433, Xelide, N-(4-{2-[methyl(2-{4-[(methylsulfonyl)amino]phenoxy}ethyl)amino]ethyl}phenyl)methanesulfonamide, SMR000466333, Tikosyn (TN), CAS-115256-11-6, UK 68,798, UNII-R4Z9X1N2ND, HSDB 7927, 1-(4-methanesulphonamidophenoxy)-2-(n-(4-methanesulphonamidophenethyl)-n-methylamino)ethane, Dofetilide [USAN:USP:INN:BAN], Dofetilide- Bio-X, UK68798, DOFETILIDE [MI], DOFETILIDE [INN], DOFETILIDE [JAN], DOFETILIDE [USAN], DOFETILIDE [VANDF], DOFETILIDE [MART.], DOFETILIDE [USP-RS], DOFETILIDE [WHO-DD], SCHEMBL16135, Dofetilide (JAN/USP/INN), MLS000759442, MLS001424185, MLS006010154, DOFETILIDE [EMA EPAR], GTPL2604, DOFETILIDE [ORANGE BOOK], Dofetilide, >=98% (HPLC), DOFETILIDE [USP MONOGRAPH], HMS2051N14, HMS2089F03, HMS2232H19, HMS3261G03, HMS3370B18, HMS3393N14, HMS3655A17, HMS3715H20, ACT04222, BCP04770, HY-B0232, Tox21_112178, Tox21_500351, AC-385, BDBM50031720, HB1078, NSC786034, s1658, AKOS005259921, Tox21_112178_1, BCP9000619, CCG-101037, DB00204, NC00287, NSC-786034, UK68789, MRF-0000317, N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methyl-amino]ethyl]phenyl]methanesulfonamide, NCGC00164549-02, NCGC00261036-01, BD164377, BCP0726000009, DB-041252, FT-0631076, SW197667-2, C07751, D00647, H11953, AB00639976-06, AB00639976-08, AB00639976_09, A803396, EN300-19768191, SR-01000759368, J-003271, Q3712521, SR-01000759368-4, BRD-K86887724-001-05-6, Dofetilide, United States Pharmacopeia (USP) Reference Standard, .BETA.-((P-METHANESULFONAMIDOPHENETHYL)METHYLAMINO)METHANESULFONO-P-PHENETIDIDE, 1-(4-Methansulphonamidophenoxy)-2-[N-(4-methanesulphonamidophenethyl)-N-methylamino]ethane, N-[4-[2-[2-(4-methanesulfonamidophenyl)ethyl-methylamino]ethoxy]phenyl]methanesulfonamide, (Dofetilide) N-[4-(2-{[2-(4-Methanesulfonylamino-phenyl)-ethyl]-methylamino}-ethoxy)-phenyl]-methanesulfonamide, 1-(4-Methanesulphonamidophenoxy)-2-[N-(4-methanesulphonamidophenethyl)-N-methylamino] ethane, N-[4-(2-{[2-(4-methanesulfonamidophenoxy)ethyl](methyl)amino}ethyl)phenyl]methanesulfonamide, N-[4-(2-{[2-(4-methanesulfonamidophenyl)ethyl](methyl)amino}ethoxy)phenyl]methanesulfonamide, N-[4-(2-{[2-(4-methanesulfonylamino-phenoxy)-ethyl]-methyl-amino}-ethyl)-phenyl]-methanesulfonamide, N-[4-(2-{[2-(4-Methanesulfonylamino-phenyl)-ethyl]-methyl-amino}-ethoxy)-phenyl]-methanesulfonamide (dofetilide), N-[4-(2-{[2-(4-Methanesulfonylamino-phenyl)-ethyl]-methyl-amino}-ethoxy)-phenyl]-methanesulfonamide (UK-68798), N-[4-(2-{[2-(4-METHANESULFONYLAMINO-PHENYL)-ETHYL]-METHYL-AMINO}-ETHOXY)-PHENYL]-METHANESULFONAMIDE DOFETILIDE
Pubchem:PUBCHEM:71329
Id:17f94a59-d3be-5269-86a3-2d2692aea3fa
Description:nan
